Lexaria’s Human GLP-1 Study #5 Receives Independent Review Board Approval
Go back to Lexaria’s Human GLP-1 Study #5 Receives Independent Review Board Approval| (NASDAQ: LEXX) | Delayed: 10.32 +1.28 (14.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.04 | 52 Week High | $ | |||
| Open | $9.31 | 52 Week Low | $ | |||
| Day High | $10.46 | P/E | N/A | |||
| Day Low | $8.74 | EPS | $ | |||
| Volume | 35,112 | |||||
| (NASDAQ: LEXXW) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $0.00 | 52 Week Low | $ | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $ | |||
| Volume | 244,027 | |||||
